Biology subjects

Chhuon, C.

Publications and source records attributed to Chhuon, C..

4 recordsLinked to original sources

bioRxiv2026

Serum Proteomics Profiling in Newborns: Differences Compared to Adults serum and new molecular markers for neonatal Sepsis

BackgroundNeonatal sepsis is a major cause of morbidity and mortality, particularly in low- and middle-income countries such as Senegal, where incidence is 78-104 per 1,000 live births and mortality exceeds 20 per 1,000, with case fatality rates around 36%. Diagnosis is difficult due to non-specific clinical signs and lack of molecular biomarkers, highlighting the need for improved early diagnostic molecular markers that could be applied even outside of hospital settings. ObjectivesCompare neonatal and adult serum proteomes to establish a reference and identify serum protein biomarkers of neonatal sepsis. MethodsSerum samples from Senegalese neonates and adults were analyzed using data-independent acquisition (DIA) proteomics on neat serum (Evosep-timsTOF HT platform). The cohort comprised 6 neonates with non-confirmed sepsis (NCS), 22 with confirmed sepsis (CS), 17 healthy newborn controls (HC), 6 unclassified and 20 healthy adults. Downstream analyses included differential protein abundance testing, unsupervised clustering, weighted gene co-expression network analysis (WGCNA), and correlation analyses with clinical parameters. ResultsWe identified 979{+/-}20 proteins in newborns versus 718{+/-}40 in adults. Newborns showed reduced immune-response proteins, a narrower dynamic range, and increased structural proteins such as collagens, consistent with immune immaturity and tissue development. Unsupervised WGCNA analysis led to a 53-protein cluster discriminated CS from NCS/HC. Some of these dysregulated proteins identified have already been reported in independent studies using different approaches in neonatal and/or adult sepsis. Our larger panel however of identified markers maps to three major biological processes involved in sepsis: (i) pathogen sensing (LBP, CD14), and acute-phase inflammation (e.g. CRP, SAA1/2, ORM1/2); (ii) innate immune activation and leukocyte recruitment (e.g., FCGR3A, CSF1R, CD163, CD206) and final platelet exhaustion and metabolic dysregulation, (e.g., PF4, PPBP, THBS1, GP5); (iii) endothelial injury and microvascular dysfunction with tissue remodeling (e.g., ICAM1, VCAM1, VWF, SPARC) and loss of protective lipoproteins and serpins (e.g., APOA1, APOA2, APOM, SERPINA4, SERPINA5) ConclusionThis study provides a very comprehensive neonatal serum proteome characterization and identifies, for the first time, a protein panel of proteins mapped to three major processes in sepsis.

pathology↗

bioRxiv2023

The PP1 phosphatase exhibits pleiotropic roles controlling both the tachyzoite cell cycle and amylopectin-steady state levels in Toxoplasma gondii.

Virulence of apicomplexan parasites is based on their ability to divide rapidly to produce significant biomass. The regulation of their cell-cycle is therefore key to their pathogenesis. Phosphorylation is a crucial post-transcriptional modification that regulates many aspects of the eucaryotic cell cycle. The phosphatase PP1 is known to play a major role in the phosphorylation balance in eukaryotes. We explored the role of TgPP1 during the cell cycle of the tachyzoite form of the apicomplexan parasite Toxoplasma gondii. Using a conditional mutant strain, we show that TgPP1 regulates many aspects of the cell cycle including the proper assembly of the daughter cells inner membrane complex (IMC), the segregation of organelles and nuclear division. Unexpectedly, depletion of TgPP1 also results in the accumulation of amylopectin, a storage polysaccharide that is normally found in the latent bradyzoite form of the parasite. Using transcriptomics and phosphoproteomics, we show that TgPP1 mainly acts through post-transcriptional mechanisms by dephosphorylating target proteins including IMC proteins. TgPP1 also dephosphorylate a protein bearing a starch binding domain. Mutagenesis analysis reveals that the targeted phospho-sites are linked to the ability of the parasite to regulate amylopectin steady-state levels. Therefore, we show that TgPP1 has pleiotropic roles during the tachyzoite cell cycle regulation, but also regulates amylopectin accumulation.

microbiology↗

bioRxiv2021

The Pentose Phosphate Pathway constitutes a major metabolic hub in pathogenic Francisella

Metabolic pathways are now considered as intrinsic virulence attributes of pathogenic bacteria and hence represent potential targets for anti-bacterial strategies. Here, we addressed the role of the pentose phosphate pathway (PPP) and its connections with other metabolic pathways in the pathophysiology of Francisella novicida. The involvement of the PPP in Francisella intracellular life cycle was first demonstrated with the study of PPP inactivation mutants. Indeed, inactivation of tktA, rpiA or rpe genes, severely impaired intramacrophagic multiplication during the first 24 hours. Time-lapse video microscopy demonstrated that rpiA and rpe mutants were able to resume late intracellular bacterial multiplication. To get further insight into the links between the PPP and other metabolic networks of the bacterium, we next performed a thorough proteo-metabolomic analysis of these mutants. We show that the PPP constitutes a major bacterial metabolic hub with multiple connections with glycolysis, tricarboxylic acid cycle and other pathways, such as fatty acid degradation and sulfur metabolism. Hence, our study highlights how the PPP is instrumental to Francisella pathogenesis and growth in its intracellular niche.

microbiology↗

bioRxiv2018

Persistent Staphylococcus aureus infections in children with chronic lung disease: a multi-omics analysis of bacterial adaptation to define novel therapeutic approaches

BackgroundChronic lung infection of cystic fibrosis (CF) patients by Staphylococcus aureus is a well-established epidemiological fact. Indeed, S. aureus is the most commonly identified pathogen in the lungs of CF patients. Strikingly the molecular mechanisms underlying S. aureus persistency are not understood.\n\nMethodsWe selected pairs of sequential S. aureus isolates from 3 patients with CF and from one patient with non-CF chronic lung disease. We used a combination of genomic, proteomic and metabolomic approaches with functional assays for in-depth characterization of S. aureus long-term persistence.\n\nResultsFor the first time, we show that late S. aureus isolates from CF patients have an increased ability for intracellular survival in CFBE-F508del cells compared to ancestral early isolates. Importantly, the increased ability to persist intracellularly was confirmed for S. aureus isolates within the own patient F508del epithelial cells. An increased ability to form biofilm was also demonstrated.\n\nFurthermore, we identified the underlying genetic modifications inducing altered protein expression profiles and notable metabolic changes. These modifications affect several metabolic pathways and virulence regulators that could constitute therapeutic targets.\n\nConclusionsOur results strongly suggest that the intracellular environment might constitute an important niche of persistence and relapse necessitating adapted antibiotic treatments.\n\nSummaryS. aureus persists for years in the lungs of patients with cystic fibrosis despite antibiotic therapies. We demonstrate that S. aureus adaptation leads to increased intracellular persistence suggesting a key role for intracellular niche during S. aureus chronic lung infection.

microbiology↗